GlassScriptPhysician profile
Cheryl A Mongera
NPI 1942288238
$2,267.86
in general payments reported to CMS, 2019-2025
19 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $281 · 2022: $598 · 2023: $1,006 · 2024: $176 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $481.09 | 2023-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $285.91 | 2021-2024 | Jardiance, Mounjaro, Emgality |
| Novo Nordisk INC | $247.26 | 2021-2023 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $223.33 | 2021-2024 | |
| Abbvie INC. | $176.91 | 2022-2023 | |
| Glaxosmithkline, LLC. | $150.64 | 2021-2022 | |
| Amgen INC. | $113.70 | 2023 | Repatha, Prolia, Evenity |
| Biohaven Pharmaceutical Holding Company LTD. | $94.19 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $69.47 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $69.23 | 2023 | |
| Merck Sharp & Dohme LLC | $63.53 | 2021-2023 | Steglatro, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.58 | 2021-2023 | Jardiance, Synjardy |
| E.R. Squibb & Sons, L.L.C. | $52.42 | 2021-2022 | |
| Astellas Pharma US INC | $51.61 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $44.86 | 2022-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $39.57 | 2023 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $17.94 | 2023 | Nuzyra |
| Amarin Pharma, INC. | $17.70 | 2021 | |
| Abbott Laboratories | $13.92 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Mongera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.